Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy

New England Journal of Medicine

Volumn 362, Issue 9, 2010, Pages 790-799

  Glauser, Tracy A ^a,b   Cnaan, Avital ^c   Shinnar, Shlomo ^d   Hirtz, Deborah G ^e   Dlugos, Dennis ^f   Masur, David ^d   Clark, Peggy O ^a   Capparelli, Edmund V ^g   Adamson, Peter C ^f  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^f CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^g UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHOSUXIMIDE; LAMOTRIGINE; VALPROATE SEMISODIUM; ANTICONVULSIVE AGENT; TRIAZINE DERIVATIVE; VALPROIC ACID;

ABSENCE; ARTICLE; ATTENTION DISTURBANCE; BENIGN CHILDHOOD EPILEPSY; BODY MASS; CHEMOTHERAPY INDUCED EMESIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECREASED APPETITE; DEPRESSION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HOSTILITY; HUMAN; HYPERACTIVITY; INCREASED APPETITE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MENTAL CONCENTRATION; MONOTHERAPY; MULTICENTER STUDY; NAUSEA; NAUSEA AND VOMITING; NEUROPSYCHOLOGICAL TEST; PERSONALITY DISORDER; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; TONIC CLONIC SEIZURE; TREATMENT DURATION; TREATMENT OUTCOME; WEIGHT GAIN; ADOLESCENT; ANALYSIS OF VARIANCE; ATTENTION DEFICIT DISORDER; BLOOD; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; INTENTION TO TREAT ANALYSIS; KAPLAN MEIER METHOD; SEIZURE;

ADOLESCENT; ANALYSIS OF VARIANCE; ANTICONVULSANTS; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; EPILEPSY, ABSENCE; ETHOSUXIMIDE; FEMALE; HUMANS; INTENTION TO TREAT ANALYSIS; KAPLAN-MEIERS ESTIMATE; MALE; SEIZURES; TREATMENT OUTCOME; TRIAZINES; VALPROIC ACID;

EID: 77649319457     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0902014     Document Type: Article

References (37)

1. Berg AT, Shinnar S, Levy SR, Testa FM, Smith-Rapaport S, Beckerman B. How well can epilepsy syndromes be identified at diagnosis? A reassessment 2 years after initial diagnosis. Epilepsia 2000;41:1269-75.
2. Jallon P, Loiseau P, Loiseau J. Newly diagnosed unprovoked epileptic seizures: presentation at diagnosis in CAROLE study. Epilepsia 2001;42:464-75.
3. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.
4. Loiseau P, Duché B, Pédespan JM. Absence epilepsies. Epilepsia 1995;36:1182-6.
5. Bouma PA, Westendorp RG, van Dijk JG, Peters AC, Brouwer OF. The outcome of absence epilepsy: a meta-analysis. Neurology 1996;47:802-8.
6. Wirrell EC, Camfield CS, Camfield PR, Dooley JM, Gordon KE, Smith B. Long-term psychosocial outcome in typical absence epilepsy: sometimes a wolf in sheeps' clothing. Arch Pediatr Adolesc Med 1997;151:152-8.
7. Pavone P, Bianchini R, Trifiletti RR, Incorpora G, Pavone A, Parano E. Neuropsychological assessment in children with absence epilepsy. Neurology 2001;56:1047-51.
8. Wheless JW, Clarke DF, Carpenter D. Treatment of pediatric epilepsy: expert opinion, 2005. J Child Neurol 2005;20: Suppl 1:S1-S56.
9. Glauser T, Ben-Menachem E, Bourgeois B, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006;47:1094-120.
10. French JA, Pedley TA. Initial management of epilepsy. N Engl J Med 2008; 359:166-76.
11. Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol 2003;2:473-81.
12. Conners CK. Conners' Continuous Performance Test II: technical guide and software manual. North Tonawanda, NY: Multi-Health Systems, 2002.
13. Wechsler D. Wechsler Intelligence Scale for Children. 4th ed. San Antonio, TX: Psychological Corporation, 2003.
14. Idem. Wechsler Intelligence Scale for Children. 3rd ed. San Antonio, TX: Psychological Corporation, 1991.
15. Brown L, Sherbenou RJ, Johnson SK. Test of Nonverbal Intelligence. 3rd ed. Austin, TX: Pro-Ed, 1997.
16. Dunn LM, Dunn LM. Peabody Picture Vocabulary Test-III. Circle Pine, MN: American Guidance Services, 1997.
17. Sheslow D, Adams W. Wide Range Assessment of Memory and Learning. 2nd ed. Wilmington, DE: Wide Range, 2003.
18. Korkman M, Kirk U, Kemp S. NEPSY-II: administration manual. San Antonio, TX: Psychological Corporation, 2005.
19. Idem. NEPSY: a developmental neuropsychological assessment manual. San Antonio, TX: Psychological Corporation, 1998.
20. Beery KE, Buktenica NA, Beery NA. Beery-Buktenica Developmental Test of Visual-Motor Integration. 5th ed. Cleveland: Modern Curriculum Press, 1997.
21. Heaton KR, Chelune GJ, Talley JL, Kay GG, Curtis G. Wisconsin Card Sorting Test manual: revised and expanded. Odessa, FL: Psychological Assessment Resources, 1993.
22. Heaton RK. Wisconsin Card Sorting Test manual. Odessa, FL: Psychological Assessment Resources, 1981.
23. Wilkinson GS. The Wide Range Achievement Test. 3rd ed. Wilmington, DE: Jastak, 1993.
24. Woodcock RW, McGrew KS, Mather N. Woodcock-Johnson III Tests of Achievement. Itasca, IL: Riverside Publishing, 2007.
25. Achenbach TM, Rescorla LA. Manual for ASEBA School Age Forms & Profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth & Families, 2001.
26. Idem. Manual for ASEBA Preschool Forms & Profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth & Families, 2000.
27. Sabaz M, Cairns DR, Lawson JA, Nheu N, Bleasel AF, Bye AM. Validation of a new quality of life measure for children with epilepsy. Epilepsia 2000;41:765-74.
28. Kim K, DeMets D. Design and analysis of group sequential tests based on the type I error spending rate function. Biometrika 1987;74:149-54.
29. Bourgeois BF. Determining the effects of antiepileptic drugs on cognitive function in pediatric patients with epilepsy. J Child Neurol 2004;19:Suppl 1:S15-S24.
30. Callaghan N, O'Hare J, O'Driscoll D, O'Neill B, Daly M. Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal). Dev Med Child Neurol 1982;24:830-6.
31. Martinovic Z. Comparison of etho-suximide with sodium valproate. In: Parsonage M, Grant RHE, Craig AG, Ward AW Jr, eds. Advances in epileptology: the XIVth Epilepsy International Symposium. New York: Raven Press, 1983:301-5.
32. Buoni S, Grosso S, Fois A. Lamotrigine in typical absence epilepsy. Brain Dev 1999;21:303-6.
33. Frank LM, Enlow T, Holmes GL, et al. Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia 1999;40:973-9.
34. Holmes GL, Frank LM, Sheth RD, et al. Lamotrigine monotherapy for newly diagnosed typical absence seizures in children. Epilepsy Res 2008;82:124-32.
35. Coppola G, Auricchio G, Federico R, Carotenuto M, Pascotto A. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallelgroup study. Epilepsia 2004;45:1049-53.
36. Masur D, Shinnar S. The neuropsychology of childhood seizure disorders. In: Segalowitz SJ, Rapin I, eds. Handbook of neuropsychology. Amsterdam: Elsevier, 1992:457-70.
37. Glauser TA, Morita DM. Ethosuximide. In: Wylie E, Gupta A, Lachhwani DK, eds. The treatment of epilepsy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2005.